Law.com - AstraZeneca Settlement Expected to Yield High Payouts to Consumers
The theory of the multidistrict litigation is that pharmaceutical companies inflated published average wholesale prices, which are used by the government and other third-party payers to set drug company reimbursement rates. The companies are also alleged to have offered secret discounts to physicians, thus enabling the physicians to reap higher reimbursements, and the drug companies to maintain or increase market share.
No comments:
Post a Comment